Keyword :   chronic lymphocytic leukemia

CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?
Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)
Electrokinetic characteristics of lymphoid cells in patients with chronic and acute leukemia and non-Hodgkin’s lymphomas
Authors: Yanish Yu.V. Zaletok S.P. Sklyarenko L.М. №4(28) 2017
NOTCH1 mutations in pathogenesis of chronic lymphocytic leukemia
Authors: Bilous N.I. Abramenko I.V. Chumak A.A. Kryachok I. №2(26) 2017
Clinical case of the coexistence of lymphoproliferative and myeloprolipherative neoplasms in three patients
Authors: Karnabeda O.A. Stupakova Z.V. №2(26) 2017
Lipids in pathogenesis of chronic lymphocytic leukemia
Authors: Abramenko I.V. Bilous N.I. Kryachok I. №1(25) 2017
Factors associated with presence of unfavorable ТР53 and SF3B1 mutations in chronic lymphocytic leukemia patients
Authors: Abramenko I.V. Bilous N.I. Kryachok I. Martіna Z.V.... №1(21) 2016
SNP309 polymorphism in the MDM2 gene in evaluation of chronic lymphocytic leukemia outcome in combination with other prognostic markers
Authors: Bilous N.I. Abramenko I.V. Kryachok I. Martіna Z.V.... №1(17) 2015
Chronic lymphocytic leukemia: new in treatment Approaches to the first-line treatment and their evolution
Author:Kryachok I. №3(11) 2013
INTERACTIONS BETWEEN LEUKEMIC CELLS AND MICROENVIRONMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: NEW ASPECTS OF PATHOGENESIS AND TARGET THERAPY
Authors: Abramenko I.V. Kryachok I. №5 (1) 2012
The determination of immunoglobulin variable heavy chain (ighv) gene mutational status in chronic lymphocytic leukemia patients: interpretation of the results
Authors: Abramenko I.V. Bilous N.I. Kryachok I. Martіna Z.V.... №4 (4) 2011